Your institution may have access to this item. Find your institution then sign in to continue.
Title
Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease.
Authors
Roberts, Andrew W.; Seymour, John F.; Brown, Jennifer R.; Wierda, William G.; Kipps, Thomas J.; Seong Lin Khaw; Carney, Dennis A.; He, Simon Z.; Huang, David C. S.; Hao Xiong; Yue Cui; Busman, Todd A.; McKeegan, Evelyn M.; Krivoshik, Andrew P.; Enschede, Sari H.; Humerickhouse, Rod
Publication
Journal of Clinical Oncology, 2012, Vol 30, Issue 5, p488